Crossmark Global Holdings’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,043
Closed -$195K 1367
2025
Q1
$195K Hold
11,043
﹤0.01% 1274
2024
Q4
$268K Buy
11,043
+27
+0.2% +$771 ﹤0.01% 1088
2024
Q3
$409K Buy
+11,016
New +$411K 0.01% 950
2024
Q2
Sell
-8,353
Closed -$319K 1342
2024
Q1
$319K Buy
+8,353
New +$272K 0.01% 1070
2023
Q3
Sell
-6,751
Closed -$373K 1309
2023
Q2
$373K Buy
6,751
+46
+0.7% +$2.8K 0.01% 968
2023
Q1
$429K Sell
6,705
-54
-0.8% -$3.52K 0.01% 895
2022
Q4
$329K Buy
6,759
+529
+8% +$33.2K 0.01% 982
2022
Q3
$440K Sell
6,230
-170
-3% -$14.6K 0.01% 821
2022
Q2
$454K Buy
6,400
+2,120
+50% +$137K 0.01% 845
2022
Q1
$342K Buy
4,280
+40
+0.9% +$2.98K 0.01% 1079
2021
Q4
$387K Sell
4,240
-5,560
-57% -$597K 0.01% 1019
2021
Q3
$1.26M Sell
9,800
-380
-4% -$53.2K 0.03% 543
2021
Q2
$1.55M Sell
10,180
-360
-3% -$47.4K 0.04% 471
2021
Q1
$1.11M Buy
+10,540
New +$1.06M 0.03% 559

Other funds holding STAA

Crossmark Global Holdings's STAA Position: Q2 2025 in Review

Crossmark Global Holdings sold out of STAAR Surgical (STAA) in Q2 2025, closing a stake of 11,043 shares — an estimated $195K sold.

Crossmark Global Holdings first reported a position in STAA in Q1 2021 and held it in 14 quarters. The position peaked at $1.55M in Q2 2021. 170 funds tracked by Wall St. Rank hold STAA as of Q2 2025.

  • Crossmark Global Holdings reported no remaining STAAR Surgical position as of Q2 2025 after selling out during the quarter.
  • Crossmark Global Holdings sold 11,043 STAAR Surgical shares in Q2 2025, an estimated $195K.
  • Crossmark Global Holdings first reported a position in STAAR Surgical in Q1 2021 and held it in 14 quarters.
  • Crossmark Global Holdings's STAAR Surgical position peaked at $1.55M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2025.

Based on Crossmark Global Holdings's 13F filing for Q2 2025, filed 8 Aug 2025.